Standard Dose

Standard Dose operates as a curated online and retail platform specializing in high-quality, third-party tested CBD and broader plant-based wellness products. The company offers a meticulously vetted selection of items, including tinctures, topicals, and supplements, with a strong emphasis on transparency and providing comprehensive educational resources to guide consumers through the complex wellness market.

The company was founded in 2019 by Anthony Saniger, who recognized a significant gap in the rapidly expanding CBD industry: a lack of trusted sourcing and clear, reliable information for consumers. Saniger's insight led to the creation of Standard Dose, aiming to establish rigorous standards for product quality and foster consumer confidence and understanding in a fragmented and often confusing space.

Standard Dose caters to health-conscious individuals who are actively seeking safe, effective, and natural solutions for their well-being. The company’s overarching vision is to demystify the potential of plant-based remedies, enabling customers to confidently explore, understand, and integrate beneficial ingredients into their daily routines for sustained health and improved quality of life.

High-Level Overview

Standard Dose was a wellness e-commerce company founded in 2019 that curated and sold vetted CBD and plant-based wellness products, emphasizing transparency through rigorous lab testing and education.[1][2][3] It targeted consumers seeking high-quality, reliable CBD solutions for well-being, operating initially with a physical store in New York before pivoting to online-only during the 2020 pandemic; the company raised $2M in seed funding but ceased operations around 2023, marked as "Dead" with its website down and UK entity dissolved.[1][2][4][6] Despite early buzz post-Farm Bill legalization, it struggled with vendor payments and never reopened its brick-and-mortar location, ending with minimal activity by September 2023.[4][6]

Origin Story

Standard Dose was founded in January 2019 by Anthony Saniger, CEO of creative agency Act Second, launching just one month after the U.S. Farm Bill legalized hemp-derived CBD trade.[2][4] Saniger curated a selection of topical and ingestible CBD brands, vetting them via a three-pronged process: requiring lab tests from brands, followed by independent third-party verification to confirm CBD content accuracy.[2] The company gained quick media attention from outlets like Vogue, Forbes, and Well+Good, opened a three-story Manhattan store-cum-event space in September 2019 near Madison Square Park, and secured seed funding led by Lucas Brand Equity's LB Equity Emerging Growth Fund—its first investment in cannabis-related ventures.[1][4] Early traction included plans for expansion, but the COVID-19 pandemic forced store closure in 2020, shifting to e-commerce only.[4]

Core Differentiators

• Vetting and Transparency Process: Unique three-step validation for every product—brand-submitted lab tests plus independent third-party testing—to ensure CBD contents matched labels, building trust in a nascent, unregulated market.[2]
• Curated High-End Selection: Focused on premium plant-based wellness and CBD items from brands like Vitruvi, Maude, Ursa Major, and Herbivore, positioning as a "mini-Amazon" for vetted CBD rather than mass-market offerings.[1][4]
• Omnichannel Start with Education Focus: Combined e-commerce, content platform, and initial physical experiential store to educate on plant-based wellness, differentiating from pure delivery competitors like Eaze or Nugg.[1][3][4]
• Targeted Premium Experience: Aimed at discerning consumers prioritizing quality, service, and efficacy over broad cannabis retail, with features like customer emails and social content until shutdown.[4][5]

Role in the Broader Tech Landscape

Standard Dose rode the explosive post-2018 Farm Bill CBD boom within the $11B+ U.S. wellness e-commerce sector, capitalizing on rising demand for transparent, plant-based alternatives amid skepticism over unverified products.[1][2][4] Its timing aligned with hemp legalization, enabling quick entry into beauty/personal care and e-commerce expert collections, but market forces like the 2020 pandemic disrupted physical retail while intensifying online competition from cannabis marketplaces (e.g., Eaze, Meadow Care).[1][4] The company highlighted early ecosystem challenges—vendor payment issues and funding hurdles—mirroring volatility in cannabis tech, where it influenced by proving demand for vetted curation but ultimately underscored scaling risks without sustained capital.[1][4]

Quick Take & Future Outlook

Standard Dose's shutdown reflects the high failure rate in early CBD retail amid regulatory flux, payment woes, and post-pandemic shifts, with no revival indicated as of its 2023 dissolution.[1][4][6] Looking ahead, its model could inspire future players in a maturing $50B+ global wellness market, where AI-driven vetting and blockchain transparency address past trust gaps. Survivors may consolidate curation into larger platforms, evolving Standard Dose's transparency legacy into enduring e-commerce standards for plant-based health.